HeartSciences Past Earnings Performance
Past criteria checks 0/6
HeartSciences's earnings have been declining at an average annual rate of -17.9%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 853.8% per year.
Key information
-17.9%
Earnings growth rate
29.5%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 853.8% |
| Return on equity | -122.9% |
| Net Margin | -39,193.8% |
| Last Earnings Update | 31 Jul 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How HeartSciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Jul 24 | 0 | -7 | 4 | 4 |
| 30 Apr 24 | 0 | -7 | 3 | 3 |
| 31 Jan 24 | 0 | -6 | 4 | 2 |
| 31 Oct 23 | 0 | -6 | 3 | 3 |
| 31 Jul 23 | 0 | -6 | 3 | 3 |
| 30 Apr 23 | 0 | -6 | 4 | 2 |
| 31 Jan 23 | 0 | -7 | 3 | 3 |
| 31 Oct 22 | 0 | -7 | 3 | 3 |
| 31 Jul 22 | 0 | -6 | 2 | 3 |
| 30 Apr 22 | 0 | -5 | 2 | 3 |
| 31 Jan 22 | 0 | -4 | 1 | 2 |
| 30 Apr 21 | 0 | -2 | 1 | 2 |
| 30 Apr 20 | 0 | -4 | 2 | 2 |
Quality Earnings: HSCS is currently unprofitable.
Growing Profit Margin: HSCS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HSCS is unprofitable, and losses have increased over the past 5 years at a rate of 17.9% per year.
Accelerating Growth: Unable to compare HSCS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HSCS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.4%).
Return on Equity
High ROE: HSCS has a negative Return on Equity (-122.85%), as it is currently unprofitable.